NovaBridge Biosciences (NASDAQ:NBP) showed up in the 13F filings of 57 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 12,065,300 | 3,628,659 | 43.01% | $29,620,312.00 |
| HHLR ADVISORS, LTD. | 31 Mar, 2026 | 5,980,568 | 0 | 0.00% | $14,712,197.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,838,198 | 52,696 | 1.39% | $9,441,967.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 3,000,000 | 0 | 0.00% | $7,380,000.00 |
| AIHC Capital Management Ltd | 31 Mar, 2026 | 2,262,933 | 1,848,954 | 446.63% | $5,566,815.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 1,389,403 | -909,098 | -39.55% | $3,417,931.00 |
| Candriam S.C.A. | 31 Mar, 2026 | 1,132,563 | 0 | 0.00% | $2,786,105.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 1,000,000 | 0 | 0.00% | $2,460,000.00 |
| Woodline Partners LP | 31 Mar, 2026 | 700,000 | -350,000 | -33.33% | $1,722,000.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 627,496 | 9,149 | 1.48% | $1,543,640.00 |
| Exome Asset Management LLC | 31 Mar, 2026 | 576,960 | 77,373 | 15.49% | $1,419,322.00 |
| State Street Corp | 31 Mar, 2026 | 370,107 | 10,229 | 2.84% | $910,463.00 |
| Fiera Capital Corp | 31 Mar, 2026 | 315,681 | 315,681 | 0.00% | $776,575.00 |
| Barclays Plc | 31 Mar, 2026 | 299,299 | -329,624 | -52.41% | $736,275.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 272,412 | 272,412 | 0.00% | $670,134.00 |
| Taikang Asset Management (Hong Kong) Co Ltd | 31 Mar, 2026 | 170,931 | 42,166 | 32.75% | $420,490.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 166,616 | 166,616 | 0.00% | $409,875.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 146,322 | -2,130 | -1.43% | $359,952.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 112,463 | -169,429 | -60.10% | $276,659.00 |
| HRT FINANCIAL LP | 31 Mar, 2026 | 107,524 | 107,524 | 0.00% | $264.00 |